 BRENTWOOD, Tenn, Nov. 30, 2020 GLOBE NEWSWIRE -- IMAC Holdings, Inc. Nasdaq: IMAC IMAC or the Company, a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, today announces that it has received a letter from The Nasdaq Stock Market LLC Nasdaq that IMAC has regained compliance with Nasdaqs minimum bid price for continued listing on the Nasdaq Capital Market set forth in Nasdaq Listing Rule 5550a2. 